an independent news feed from Current Medicine Group™
- Latest oncology research
- Clinical trials
- Healthcare initiatives
- Practice guidelines
-
- Mar 9, 2010
- Sarcosine fails as marker for prostate cancer detection Patients with and without prostate cancer cannot be differentiated by the levels of sarcosine in their urine following rectal digital examination, researchers report.
-
- Mar 8, 2010
- ERG/ETVI and PTEN gene loci identify death risk in prostate cancer patients Patients at low and high risk for death from prostate cancer can be identified by the presence or absence of the phosphatase and tensin homolog gene and gene rearrangements in
-
- Mar 8, 2010
- Increasing hospital admission rate for complications after TRUS-guided biopsy The hospital admission rates for complications following transrectal ultrasound-guided prostate biopsy increased dramatically between 1996 and 2005 in Ontario, Canada, and this is primarily due to an increasing rate of infection-related complications, researchers report.
-
- Mar 5, 2010
- High doses required for optimal local control after prostate brachytherapy Prostate cancer patients treated with permanent prostate brachytherapy who receive a biologically effective dose of more than 200 Gy achieve significantly better local control than patients who receive lower doses of radiation, researchers report.
-
- Mar 4, 2010
- Secreted caveolin-1 potential biomarker for prostate cancer Secreted caveolin-1 has potential as a biomarker for prostate cancer, indicates a review published in the journal
-
- Mar 4, 2010
- Risk of prostate cancer recurrence after RP varies even among experienced surgeons The risk for prostate cancer recurrence after radical prostatectomy for localized disease varies greatly between experienced surgeons, researchers report.
-
- Mar 3, 2010
- Stereotactic body radiotherapy achieves low toxicity and maintains QoL Stereotactic body radiotherapy achieves low toxicity and maintains quality of life in patients with localized prostate cancer, researchers report.
-
- Mar 2, 2010
- Prognostic factor estimates unaffected by biochemical recurrence definition Prognostic factors for biochemical recurrence in men who have undergone radical prostatectomy should give similar results irrespective of the definition of biochemical recurrence used, research suggests.
-
- Mar 2, 2010
- RARP ‘safe option’ for clinically localized prostate cancer Robotic-assisted radical prostatectomy is a “safe option” for the treatment of clinically localized prostate cancer, say researchers who found low complication rates in a single-surgeon series of the procedures.
-
- Mar 1, 2010
- Low disease burden predicts favorable PSA after cryoablation Low disease burden prior to primary prostate cryoablation is highly prognostic for having an initial post-cryoablation PSA below 0.6 ng/ml, researchers report.
Not signed in
Information
This is an AstraZeneca International website for healthcare professionals and is not intended for the following audiences who should use the links below.
Subscribe to RSS News Feed